Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide for Hippocampal Function in Prediabetes
NCT02140983Phase 1Completed
- Sponsor
- Stanford University
- Start
- Aug 2013
- Primary completion
- Feb 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in prediabetes and insulin resistance (IR) comparing Liraglutide with Placebo (2 arms). Primary endpoints: Cognitive Outcomes at 3 months, Oral Glucose Tolerance Test at 3 months and 3 more. Started Aug 2013; status: completed.
02
Drugs
03
Conditions
prediabetesinsulin resistance (IR)
Beyond the preview
Go deeper on NCT02140983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02140983.